Therapeutic Drug Monitoring Markets
NEW YORK, March 25, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Therapeutic drug monitoring (TDM) is an important clinical assessment of drug plasma concentrations that also yields information regarding the efficacy, toxicity levels and potential drug-drug interactions of agents with a narrow therapeutic index. Ultimately, therapeutic drug monitoring testing provides clinical information to optimize dosage regimes and prevent adverse reactions and lack of treatment compliance.This TriMark Publications report analyzes the therapeutic drug monitoring market and the various market segments within it, e.g., antiepileptics, antiarrhythmics, antibiotics, antineoplastics, bronchodilators, immunosuppressives and HIV/AIDS drugs. The report also examines drug analysis technology platforms, clinical applications of therapeutic drug testing and the market for quantitative diagnostic drug tests. Moreover, the study analyzes almost all of the companies known to be marketing, manufacturing or developing therapeutic drug monitoring products in the U.S. and worldwide. Detailed tables and charts with sales forecasts and marketshare data are also included. TABLE OF CONTENTS 1. Overview 9 1.1 Statement of Report 9 1.2 About This Report 9 1.3 Scope of the Report 10 1.4 Objectives 10 1.5 Methodology 11 1.6 Executive Summary 12 2. Therapeutic Drug Monitoring 162.1 Introduction 162.2 Function of Therapeutic Drug Monitoring 182.3 Drug Screening Boom 202.3.1 Pain Management Drug Testing in Europe 222.3.2 Neonate Patients and Patients of Old Age 222.3.3 Therapeutic Drug Monitoring and Immunosuppressive Drugs 232.3.4 Antiretroviral Usage and TDM Monitoring 232.4 The Process of Therapeutic Drug Monitoring 25 3. Commonly Monitored Therapeutic Drugs 29 3.1 Antiepileptics 30 3.2 Antiarrhythmics 32 3.3 Antimanics 35 3.4 Antineoplastic Drugs (Anticancer Drugs) 37 3.5 Bronchodilators 39 3.6 Antibiotics 40 3.7 Immunosupressants 41 3.7.1 Interference in Immunosuppressant Drug Immunoassays1 42
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV